Finance

Lists
ALCOX:EPA
NicOx SA
€0,39
+2,64%
(+0,0100) 1D
27 Aug., 17:35:17 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALCOX...
Open
€0,40
High
€0,40
Low
€0,38
Mkt. cap
37,94 m
Avg. vol.
159,48 k
Volume
414,66 k
52-wk high
€0,57
52-wk low
€0,28
EPS
-€0,03
Shares outstanding
97,53 m
No. of employees
10
Open
€0,40
High
€0,40
Low
€0,38
Mkt. cap
37,94 m
Avg. vol.
159,48 k
Volume
414,66 k
52-wk high
€0,57
52-wk low
€0,28
EPS
-€0,03
Shares outstanding
97,53 m
No. of employees
10
News stories
From web sources and news partners
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi. Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, Frankryk
Sector-
Websitenicox.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
763,05 k
763,05 k
7,62 m
7,62 m
Cost of goods sold
2,90 m
2,90 m
2,22 m
2,22 m
Cost of revenue
2,90 m
2,90 m
2,22 m
2,22 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
421,39 k
421,39 k
478,60 k
478,60 k
Operating expense
441,99 k
441,99 k
-486,77 k
-486,77 k
Total operating expenses
3,34 m
3,34 m
1,73 m
1,73 m
Operating income
-2,58 m
-2,58 m
5,89 m
5,89 m
Other non operating income
-1,50 m
-1,50 m
-8,56 m
-8,56 m
EBT including unusual items
-4,47 m
-4,47 m
3,27 m
3,27 m
EBT excluding unusual items
-4,47 m
-4,47 m
-3,81 m
-3,81 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
18,06 k
18,06 k
-967,68 k
-967,68 k
Net income
-4,47 m
-4,47 m
3,27 m
3,27 m
Net profit margin
-586,37%
-586,37%
42,87%
42,87%
Earnings per share
-
-
-
-
Interest and investment income
186,72 k
186,72 k
66,40 k
66,40 k
Interest expense
-273,18 k
-273,18 k
-1,20 m
-1,20 m
Net interest expenses
-86,46 k
-86,46 k
-1,14 m
-1,14 m
Depreciation and amortization charges
2,54 k
2,54 k
2,31 k
2,31 k
EBITDA
-2,57 m
-2,57 m
5,89 m
5,89 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme